![Mark Robbins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Mark Robbins worked as Vice President-Clinical & Regulatory Affairs at DiaMedica Therapeutics, Inc. from 2013 to 2015.
He was also President at Tansna Therapeutics, Inc. and Chief Scientific Officer & EVP Legal Operations at Upsher-Smith Laboratories LLC.
Precedenti posizioni note di Mark Robbins
| Società | Posizione | Fine |
|---|---|---|
Tansna Therapeutics, Inc.
 Tansna Therapeutics, Inc. Medical DistributorsDistribution Services Develops and offers oral drugs to treat epilepsy | Presidente | 01/10/2018 |
| DIAMEDICA THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 20/01/2015 |
Upsher-Smith Laboratories LLC
 Upsher-Smith Laboratories LLC Pharmaceuticals: MajorHealth Technology Manufactures and markets generic pharmaceutical products | Direttore operativo | 10/01/2013 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
3
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
DiaMedica Therapeutics, Inc.
 DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Tansna Therapeutics, Inc.
Tansna Therapeutics, Inc. Medical DistributorsDistribution Services Develops and offers oral drugs to treat epilepsy | Distribution Services |
Upsher-Smith Laboratories LLC
Upsher-Smith Laboratories LLC Pharmaceuticals: MajorHealth Technology Manufactures and markets generic pharmaceutical products | Health Technology |
